Krishgen provides a wide catalog of relevant tools for COVID-19 research and clinical diagnostics, including ELISA, RT-PCR, RAPID kits and various proteins.
The ongoing pneumonia outbreak in the city of Wuhan is caused by the highly infectious coronavirus 2019-nCoV, named by the World Health Organization on January 12nd, 2020. This new virus belongs to the Betacoronavirus Genus, which also includes SARS CoV (2003) and MERS CoV (2012). The sequence similarity between 2019-nCoV and MERS-CoV is 40%, while that between 2019-nCoV and SARS-CoV is 70%.
Krishgen has been at the forefront of the SARS-CoV-2 response, manufacturing various specific assays and tests from April 2020. These products have supported a variety of research, as well as vaccine and therapy development.
Primarily, Krishgen is working on accurate, specific ELISA for antigen, and antibody studies related to COVID-19. Whether you are working with Spike protein (RBD, S1 and S2) or N-protein, and with IgG or IgM, Krishgen has the right immunoassay for you. Our species-specific ELISA kits allow for antigen and antibody quantification in human as well as animal models.
Krishgen is currently the only company in the world commercially manufacturing several of these ELISA. If you require support in choosing the right product, get in touch with our technical support team today!